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S U M M A R Y
Background: During the observation of many patients with nontuberculous mycobacteria (NTM)
infections, we have often isolated different NTM species in the same patient. In this study we elucidated
the patterns of multiple NTM species isolation.
Methods: The analysis included all patients from whom more than one species of mycobacteria were
cultured from a respiratory specimen at Seoul National University Hospital, a tertiary referral hospital in
South Korea, between January 2002 and December 2008. The demographic characteristics and clinical
and radiographic ﬁndings were reviewed retrospectively.
Results: Multiple NTM species were isolated from 37 patients. Four patients with Mycobacterium
gordonae, Mycobacterium terrae, or Mycobacterium lentiﬂavum were excluded due to the possibility of
contamination. Transition to another NTM species was observed in 23 patients (69.7%), while alternating
isolation of two or three NTM species was seen in nine patients. Two species were isolated
simultaneously from different sputum samples collected from one patient on the same day.
Conclusions: Different NTM species were isolated from the same patients.
 2011 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
International Journal of Infectious Diseases
jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Nontuberculous mycobacteria (NTM) are ubiquitous organ-
isms, which can be isolated from many environments,1,2 and more
than 125 NTM species have been identiﬁed.3,4 Although the
majority of NTM species are considered opportunistic pathogens,
some NTM, such as Mycobacterium avium-intracellulare, Mycobac-
terium kansasii, and Mycobacterium abscessus, can cause disease in
immunocompetent hosts.2,5
The treatment of NTM disease is challenging not only because of
the long treatment period with multiple antimycobacterial drugs,
but also the various treatment responses. Generally, selecting a
regimen for treating NTM disease has been based on NTM species
identiﬁcation rather than in vitro drug susceptibility tests, because
the clinical response does not correlate well with the in vitro
susceptibility to many drugs used to treat NTM disease.2
It is possible to isolate different NTM species from the same
patient during observation or treatment. In fact, the co-existence of
M. avium-intracellulare was observed in 8% of 154 patients with
lung disease caused by rapidly growing mycobacteria.6 While
observing many patients with NTM,7 we also noted that different* Corresponding author. Tel.: +82 2 2072 2059; fax: +82 2 2072 9662.
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The analysis included all patients from whom different
mycobacterial species were cultured from respiratory specimens
at Seoul National University Hospital, a tertiary referral hospital in
South Korea, between January 2002 and December 2008. The study
protocol was approved by the institutional review board of Seoul
National University Hospital.
2.2. Specimen processing
Respiratory specimens such as sputum were decontaminated
with 4% NaOH, homogenized, and concentrated by centrifugation
at 3000 g for 20 min. Processed sediment or a specimen from a
normally sterile site was stained using the Ziehl–Neelsen method.2
The acid-fast bacillus (AFB) smear results were graded according to
the American Thoracic Society (ATS)/Centers for Disease Control
and Prevention (CDC) classiﬁcation.8 Concentrated specimens
were cultured in 3% Ogawa medium and observed weekly forses. Published by Elsevier Ltd. All rights reserved.
Table 1
Characteristics of the 33 patients with multiple species of NTM
Number of patients 33
Age, years, median (range) 60 (25–79)
Male 15 (45.5%)
Ever-smoker 5 (15.2%)
Body mass index (kg/m2) 21.0  2.7
History of pulmonary tuberculosis 17 (51.5%)
Remote (more than 5 years ago) 11
Recent (within 5 years) 6
Comorbidities




Connective tissue diseases 2 (6.1%)
Chronic kidney disease 1 (3.0%)







Chest pain 1 (3.0%)
Weight loss 9 (27.3%)
Fatigue 3 (9.1%)
Laboratory ﬁndings
Leukocytes ( 109/l) 7.113  2.940
Hemoglobin (g/dl) 13.3  1.3
Cholesterol (mg/dl) 178.9  35.3
Albumin (g/dl) 3.96  0.45
Follow-up duration after initial isolation of NTM,
months, median (range)
47.2 (6.7–84.0)
Treatment state on isolation of second species of NTM
Complete treatment 6 (18.2%)
Being treated 7 (21.2%)
Being observed without treatment 20 (60.6%)
NTM, nontuberculous mycobacteria.
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and NTM were distinguished using the Gen-Probe method (Gen-
Probe1, Gen-Probe, San Diego, CA, USA).9 A polymerase chain
reaction–restriction fragment length polymorphism method was
used if the clinicians decided to identify the NTM to the species
level.10
2.3. Data collection and review
The demographic characteristics, clinical ﬁndings, and labora-
tory results were obtained from a retrospective review of the
medical records. The chest radiographs were evaluated by a board-
certiﬁed radiologist (Dr C.M. Park), who was blinded to the
patients’ clinical records. The radiographic characteristics were
evaluated based on a simple chest radiograph and computerized
tomograms, if available.
3. Results
3.1. Number and characteristics of the patients with multiple NTM
species
One thousand eight hundred and one patients with NTM
isolates were identiﬁed for the analysis. From these, 4316 NTM
were isolated during the study period. In 793 isolates from 532
patients, clinicians recognized the likelihood that the isolate was a
pathogen rather than a colonizer and species identiﬁcation was
requested. Mycobacterial species identiﬁcation was performed
two or more times for 133 patients. Finally, 37 of 133 patients were
conﬁrmed as having multiple species of NTM. Among these, we
omitted two patients with Mycobacterium gordonae, one patient
with Mycobacterium terrae, and one patient with Mycobacterium
lentiﬂavum, which are known to contaminate clinical specimens
very easily.2
The median age of the patients was 60 years and 15 (45.5%) were
male. Seventeen (51.5%) of the patients had a history of pulmonary
tuberculosis and ﬁve (15.2%) had diabetes. Sputum (13 patients,
39.4%) and cough (13 patients, 39.4%) were their most frequent
symptoms. After isolating the ﬁrst NTM, these patients were
followed for a median of 47.2 months (range 6.7–84.0 months).
When the second NTM species was isolated, six patients (18.2%) had
completed their treatment, seven (21.2%) were being treated, and 20
(60.6%) were being observed without treatment (Table 1).
3.2. Patterns of multiple NTM isolation
Among the 33 patients included in this study, two NTM species
were isolated from 29 patients (87.9%), and three species were
isolated from four patients. All but one patient were diagnosed as
having lung diseases caused by the initially isolated NTM, based on
the criteria suggested by the ATS in 2007.2 One patient with
simultaneous isolation of M. avium and M. abscessus did not satisfy
the ATS criteria.
For 23 patients (69.7%), the isolated NTM changed to a different
species, most frequently from M. avium to M. abscessus (six patients).
Changes from M. avium to M. intracellulare (three patients) and from
M. abscessus to M. avium (three patients) were also observed.
Alternating isolation of two or three NTM was also observed in nine
patients (27.3%), such asfrom M.abscessus toM.avium toM.abscessus.
In addition, we simultaneously isolated two species from different
sputumsamples collected from onepatientonthesameday(Table2).
3.3. Radiographic ﬁndings of the patients with multiple NTM species
Bronchiectasis (29 patients, 87.9%), bronchiolitis (29 patients,
87.9%), and nodules (28 patients, 84.8%) were the most commonradiographic features among the 33 patients with multiple NTM
species. A volume decrease (16 patients, 48.5%) and a cavity (10
patients, 30.3%) were also common. Involvement of the upper
lobes and right middle lobe/lingular segment was more frequent,
although lower lobe lesions were not rare (Table 3).
4. Discussion
We found that different NTM species could be isolated in the
same patients and that there were transitional, alternating, and
simultaneous patterns of change.
Although no studies have systematically analyzed the isolation of
different NTM species, the co-existence of M. avium-intracellulare
with rapidly growing mycobacteria has been recognized.6 In
addition, recent studies have identiﬁed the presence of different
M. avium-intracellulare strains in the same patient.11,12 In those
studies, different strains were isolated from patients with nodular
bronchiectatic features rather than cavitary disease.11,12 Similarly,
in our study, nodules (84.8%) and bronchiectasis (87.9%) were much
more frequent than a cavity (30.3%) among the 33 patients with
multiple NTM species isolates, suggesting that it is possible to have
different NTM species in different ectatic bronchi or nodule sites.
The clinical implications of the isolation of different NTM
species from the same patient are obscure. Wallace et al. proposed
that isolating different strains of M. avium-intracellulare was
accompanied by disease associated with the new strains.11,12
However, this seems unlikely for our study population given that
one third of patients with multiple NTM species showed the
alternating isolation of two or more NTM species. Several
possibilities (change of pathogen, co-pathogen, pathogen/coloniz-
er, and so on) could account for our observation, but are still far
from clear. The clinical signiﬁcance of the isolation of multiple
Table 2
Changing patterns of NTM species in 33 patients with multiple species of NTM




Transitional pattern 23 (69.7%) 9 8
A ! B 21
M. avium ! M. abscessus 6 3 2
M. avium ! M. intracellulare 3 1
M. abscessus ! M. avium 3 1 2
M. intracellulare ! M. avium 2 2
M. intracellulare ! M. abscessus 2 1 1
M. avium ! M. fortuitum 1 1
M. fortuitum ! M. avium 1 1
M. fortuitum ! M. kansasii 1
M. kansasii ! M. avium 1
M. xenopi ! M. abscessus 1
A ! B ! C 2
M. avium ! M. intracellulare ! M. abscessus 1 1
M. abscessus ! M. fortuitum ! M. avium 1 1
Alternating pattern 9 (27.3%) 2 1
A ! B ! A 4
M. abscessus ! M. avium ! M. abscessus 1
M. abscessus ! M. mageritense ! M. abscessus 1 1
M. abscessus ! M. intracellulare ! M. abscessus 1
M. avium ! M. abscessus ! M. avium 1
A ! B ! A ! X 4
M. abscessus ! M. avium ! M. abscessus ! M. avium ! M. abscessus 1 1
M. intracellulare ! M. abscessus ! M. intracellulare ! M. abscessus ! M. intracellulare 1
M. intracellulare ! M. avium ! M. intracellulare ! M. avium 1
M. abscessus ! M. intracellulare ! M. abscessus ! M. avium 1 1
A ! B ! C ! B ! C ! B 1
M. intracellulare ! M. avium ! M. abscessus ! M. avium! M. abscessus ! M. avium 1
Simultaneous pattern 1 (3.0%)
A and B simultaneously 1
M. avium and M. abscessus 1
NTM, nontuberculous mycobacteria.
Table 3
Radiographic ﬁndings of 33 patients with multiple NTM species isolated
CT pattern No. (%) of patientsa Distribution Location of lesions (No. of lobes)
Right lobe Left lobe Total
Unilateral Bilateral Upper Middle Lower Upper Lingular Lower
Bronchiectasis 29 (87.9) 14 15 22 17 21 10 16 14 100
Bronchiolitisb 29 (87.9) 9 20 20 20 20 12 14 13 99
Nodulesc 28 (84.8) 13 15 22 8 15 8 6 12 71
Cavity 10 (30.3) 7 3 2 2 6 2 0 3 15
Consolidation 1 (3.0) 0 1 0 0 1 0 1 1 3
Volume decrease 16 (48.5) 13 3 2 12 1 1 6 1 23
Emphysema 3 (9.1) 1 2 1 2 2 2 1 3 11
Fungus ball 1 (3.0) 1 0 1 0 0 0 0 0 1
Bullae 2 (6.1) 2 0 1 1 0 0 0 0 2
TB sequelaed 6 (18.2) 3 3 6 1 1 3 0 0 11
NTM, nontuberculous mycobacteria; CT, computed tomography; TB, tuberculosis.
a If two or more changes were present in one patient, they were counted separately.
b Bronchiolitis was deﬁned as centrilobular nodule with branching linear opacity or tree-in-bud appearance.
c Nodule was deﬁned as any focal nodular lesion except branching linear opacity; lobular consolidation was included as nodule.
d TB sequelae included ﬁbroatelectatic lung change, ﬁbrosis, and extrapleural fat proliferation.
H.-J. Lim et al. / International Journal of Infectious Diseases 15 (2011) e795–e798 e797NTM species should be elucidated through a well-designed
prospective study in the future.
One limitation of this study was that a request for species
identiﬁcation was not made for every NTM isolate. Consequently, the
proportion of patients with multiple NTM species was probably
underestimated, and the results of the analysis may be somewhat
biased. However, the fact that multiple NTM species could be isolated
in the same patient and that this might be associated with clinical
improvement or deterioration is not affected by this limitation.
In conclusion, different NTM species can be isolated from the
same patient. Clinicians should be aware that a change in the NTM
species may be associated with a change in disease status.Conﬂict of interest: All authors have no conﬂict of interest to
declare. The authors have no funding sources to declare regarding
our article.
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